Biosignature Discovery for Personalized Treatment in Depression (U01)

Archived

National Institutes of Health

View on Grants.gov 📝 Build a proposal template ★ Save

Description

Purpose. The purpose of this initiative is to support exploratory research to discover panels of promising biomarkers (i.e., biosignatures) that are predictive of treatment outcomes in major depressive disorder. Mechanism of Support: This FOA will utilize the NIH Cooperative Agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards: The NIMH expects to commit approximately $6 million in total costs in Fiscal Year 2010 to fund one or more U01 awards under this initiative.

Who can apply

  • State governments
  • Public and State controlled institutions of higher education
  • Native American tribal governments (Federally recognized)
  • Nonprofits with 501(c)(3) status (other than higher education)
  • Nonprofits without 501(c)(3) status (other than higher education)
  • Private institutions of higher education
  • For-profit organizations other than small businesses
  • Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV

Key dates & funding
  • PostedSep 16, 2009
  • ClosesJan 13, 2010
  • Program funding$6,000,000
  • CFDA93.242
Categories
Health

Pro insight

Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.

Unlock with Pro